The anesthesia CO2 absorbents industry is consolidated in nature, with major companies competing to offer superior products in this business space. Prominent players such as Drägerwerk AG & Co. KGaA holds a significant share in the market. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share. For instance, Drägerwerk AG & Co. KGaA introduced the Drägersorb 800 HEPA, in order to offer more safe and effective anesthesia CO2 absorbents in the market.
Some of the eminent market participants operating in the anesthesia CO2 absorbents industry include: